Integra Lifesciences Sees Q1 Adj EPS $0.37-$0.45 vs $0.48 Est; Sees Sales $375.000M-$390.000M vs $392.147M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Integra Lifesciences (NASDAQ:IART) is looking for Q1 Adj EPS of $0.37-$0.45 vs $0.48 analyst estimate. sees sales of $375.000 million-$390.000 million vs $392.147 million analyst estimate.
Integra Lifesciences (NASDAQ:IART) is looking for Q1 Adj EPS of $0.37-$0.45 vs $0.48 analyst estimate. sees sales of $375.000 million-$390.000 million vs $392.147 million analyst estimate.